Glen Vries - Medidata Solutions President
President
Mr. Glen M. de Vries is the President, Director of Medidata Solutions, Inc. Mr. de Vries has served as our president since February 2008 and as a member of our board of directors since 1999. From 2000 to 2008, Mr. de Vries served as our chief technology officer. Mr. de Vries has over 20 years of experience in medical software development, including electronic health records and consumertargeted products. Previously, he served as a research assistant at Columbia University focusing on both research science and creating a paperless clinical data management system. Mr. de Vries holds a B.S. in molecular biology and genetics from Carnegie Mellon University. Mr. de Vries significant experience as the companys cofounder, former chief technology officer and president provides our board of directors with unique perspectives and insights regarding the companys innovation and strategic vision. since 2008.
| Age | 44 |
| Tenure | 16 years |
| Phone | 212 918-1800 |
| Web | www.medidata.com |
Medidata Solutions Management Efficiency
The company has return on total asset (ROA) of 7.55 % which means that it generated a profit of $7.55 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 10.86 %, meaning that it created $10.86 on every $100 dollars invested by stockholders. Medidata Solutions' management efficiency ratios could be used to measure how well Medidata Solutions manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 198.87 M in liabilities with Debt to Equity (D/E) ratio of 30.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Medidata Solutions has a current ratio of 2.52, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Medidata Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, Medidata Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medidata Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medidata to invest in growth at high rates of return. When we think about Medidata Solutions' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| John Bendoraitis | Spirit Airlines | 60 | |
| Aaron Alter | Hawaiian Holdings | 66 | |
| Brandon Pedersen | Alaska Air Group | 51 | |
| Matthew Klein | Spirit Airlines | 50 | |
| Steven Sear | Delta Air Lines | 58 | |
| Edmundo Miranda | Spirit Airlines | 38 | |
| John Kirby | Spirit Airlines | N/A | |
| Rahul Samant | Delta Air Lines | 57 | |
| Michael Lotz | Mesa Air Group | 64 | |
| Shane Tackett | Alaska Air Group | 45 | |
| Christopher Berry | Alaska Air Group | 39 | |
| Diana Rakow | Alaska Air Group | 40 | |
| Ron AndersonLehman | Hawaiian Holdings | 52 | |
| Peter Carter | Delta Air Lines | 60 | |
| John Laughter | Delta Air Lines | 53 | |
| Kate Gebo | United Airlines Holdings | 55 | |
| Barbara Falvey | Hawaiian Holdings | 58 | |
| Theodoros Panagiotoulias | Hawaiian Holdings | 53 | |
| William Lentsch | Delta Air Lines | 56 | |
| Brian McMenamy | Spirit Airlines | 65 | |
| Constance Muehlen | Alaska Air Group | 58 | |
Management Performance
| Return On Equity | 10.86 | |||
| Return On Asset | 7.55 |
Medidata Solutions Leadership Team
Elected by the shareholders, the Medidata Solutions' board of directors comprises two types of representatives: Medidata Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medidata. The board's role is to monitor Medidata Solutions' management team and ensure that shareholders' interests are well served. Medidata Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medidata Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Otner, Executive Vice President General Counsel, Corporate Secretary | ||
| Lee Shapiro, Independent Director | ||
| Tarek Sherif, Co-Founder, Chairman and CEO | ||
| Hulus Alpay, Vice President - Investor Relations | ||
| Glen Vries, Co-Founder and President Director and President of Medidata Solutions Worldwide | ||
| Michael Capone, COO | ||
| Anthony DAmico, Senior Director, Investor Relations | ||
| Neil Kurtz, Independent Director | ||
| Carlos Dominguez, Independent Director | ||
| Elena Izmailova, Chief Scientific Officer | ||
| George McCulloch, Independent Director | ||
| Vik Shahwill, COO | ||
| Mary Weger, Executive Vice President—Human Resources | ||
| Michael Pinto, Executive Vice President General Manager - Global Sales | ||
| Rouven Bergmann, CFO and Chief Accounting Officer | ||
| Robert Taylor, Independent Director | ||
| Sastry Chilukuri, Executive Vice President - Digital and AI Solutions | ||
| Eileen Schloss, Executive Vice President - Human Resources | ||
| Michael Pray, Executive Vice President General Manager - Global Sales | ||
| Maria Rivas, Director | ||
| Steven Hirschfeld, Chief Commercial Officer | ||
| Betsy Frank, IR Contact Officer | ||
| Daniel Shannon, Executive Vice President – Global Professional Services | ||
| Gol Ophiris, Head - Business Development |
Medidata Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medidata Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 10.86 | |||
| Return On Asset | 7.55 | |||
| Profit Margin | 9.90 % | |||
| Operating Margin | 11.40 % | |||
| Current Valuation | 5.54 B | |||
| Shares Outstanding | 62.46 M | |||
| Shares Owned By Insiders | 3.80 % | |||
| Shares Owned By Institutions | 96.20 % | |||
| Number Of Shares Shorted | 6.1 M | |||
| Price To Earning | 128.08 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medidata Solutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medidata Solutions' short interest history, or implied volatility extrapolated from Medidata Solutions options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Medidata Stock
If you are still planning to invest in Medidata Solutions check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medidata Solutions' history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |